Table 3.
Outcomes of Na-DTCs with different size of alkyl group in SBE-bla, WNT-, RAR-, SHH-luc assays.
Sample Name | CASRN | Structure | SBE Antagonist | WNT Antagonist | RAR Antagonist | SHH Antagonist | ||||
---|---|---|---|---|---|---|---|---|---|---|
IC50 (μM) | Efficacy (%) | IC50 (μM) | Efficacy (%) | IC50 (μM) | Efficacy (%) | IC50 (μM) | Efficacy (%) | |||
Sodium dimethyldithiocarbamate | 128-04-1 | ![]() |
9.14 | −68.19 | Inactive | Inactive | 17.37 | −93.31 | 6.73 | −87.30 |
Sodium diethyldithiocarbamate | 148-18-5 | ![]() |
11.49 | −58.53 | 3.69 | −74.76 | 15.31 | −113.16 | 8.92 | −96.63 |
Sodium dibutylcarbamodithioate | 136-30-1 | ![]() |
Inactive | Inactive | Inactive | Inactive | Inactive | Inactive | Inactive | Inactive |
Potency (IC50) and efficacy (activity %) in inhibiting TGFβ WNT, RAR, and SHH pathways by sodium dimethyl-, diethyl-, and dibutyl- dithiocarbamates were compared in the table.